Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verzenio (abemaciclib)
Pharma
ESMO: Eli Lilly looks to drive Verzenio adoption with survival win
Lilly hopes the latest OS win could increase the adoption of Verzenio and, by extension, the entire CDK4/6 inhibitor class in early breast cancer.
Angus Liuu
Oct 17, 2025 8:00am
Lilly answers Novartis breast cancer rivalry with survival win
Aug 27, 2025 10:59am
Lilly logs huge Q4 revenue jump despite recent incretin letdown
Feb 6, 2025 12:56pm
Kisqali off to a 'very rapid' launch in early breast cancer: CEO
Jan 31, 2025 11:28am
Novartis pressures Lilly with Kisqali's broad breast cancer nod
Sep 17, 2024 3:04pm
Lilly lifts guidance by $3B after strong GLP-1 performance
Aug 8, 2024 11:18am
